{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:53:03Z","timestamp":1787662383149,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012503","name":"Dream Project of Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2021YFA1101700"],"award-info":[{"award-number":["2021YFA1101700"]}],"id":[{"id":"10.13039\/501100012503","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00259-023-06403-0","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T22:01:33Z","timestamp":1696370493000},"page":"434-442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism"],"prefix":"10.1007","volume":"51","author":[{"given":"Mei","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuantao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cahid Civelek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Carrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keon Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John O.","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chentao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengtao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4084-5150","authenticated-orcid":false,"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Molecular Imaging-based Precision Medicine Task Group of A3 (China-Japan-Korea) Foresight Program","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"issue":"1","key":"6403_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/mdc3.12261","volume":"3","author":"S Oravivattanakul","year":"2016","unstructured":"Oravivattanakul S, Benchaya L, Wu G, et al. Dopamine transporter (DaT) Scan utilization in a movement disorder center. Mov Disord Clin Pract. 2016;3(1):31\u20135.","journal-title":"Mov Disord Clin Pract"},{"issue":"11","key":"6403_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"Collaborators GBDPsD","year":"2018","unstructured":"Collaborators GBDPsD. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939\u201353.","journal-title":"Lancet Neurol."},{"issue":"6","key":"6403_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.sult.2020.08.006","volume":"41","author":"KM Davis","year":"2020","unstructured":"Davis KM, Ryan JL, Aaron VD, Sims JB. PET and SPECT imaging of the brain: history, technical considerations, applications, and radiotracers. Semin Ultrasound CT MR. 2020;41(6):521\u20139.","journal-title":"Semin Ultrasound CT MR"},{"issue":"8","key":"6403_CR4","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1007\/s00259-021-05234-1","volume":"48","author":"M Tian","year":"2021","unstructured":"Tian M, He X, Jin C, et al. Transpathology: molecular imaging-based pathology. Eur J Nucl Med Mol Imaging. 2021;48(8):2338\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"6403_CR5","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00259-020-04817-8","volume":"47","author":"S Morbelli","year":"2020","unstructured":"Morbelli S, Esposito G, Arbizu J, et al. EANM practice guideline\/SNMMI procedure standard for dopaminergic imaging in parkinsonian syndromes 1.0. Eur J Nucl Med Mol Imaging. 2020;47(8):1885\u2013912.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"12","key":"6403_CR6","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30(12):1591\u2013601.","journal-title":"Mov Disord"},{"issue":"17","key":"6403_CR7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith IG, Ferman TJ, Thomas AJ, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94(17):743\u201355.","journal-title":"Neurology"},{"issue":"8","key":"6403_CR8","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/RLU.0000000000002148","volume":"43","author":"FT Liu","year":"2018","unstructured":"Liu FT, Ge JJ, Wu JJ, et al. Clinical, dopaminergic, and metabolic correlations in Parkinson disease: a dual-tracer PET study. Clin Nucl Med. 2018;43(8):562\u201371.","journal-title":"Clin Nucl Med"},{"key":"6403_CR9","doi-asserted-by":"publisher","unstructured":"Yang Y, Ge J, Liu F, et al. Preserved caudate function in young-onset patients with Parkinson\u2019s disease: a dual-tracer PET imaging study. Ther Adv Neurol Disord. 2019;12:1756286419851400.\u00a0https:\/\/doi.org\/10.1177\/1756286419851400.","DOI":"10.1177\/1756286419851400"},{"key":"6403_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.627356","volume":"13","author":"L Han","year":"2021","unstructured":"Han L, Lu J, Tang Y, et al. Dopaminergic and metabolic correlations with cognitive domains in non-demented Parkinson\u2019s disease. Front Aging Neurosci. 2021;13: 627356.","journal-title":"Front Aging Neurosci"},{"issue":"Pt 2","key":"6403_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/brain\/119.2.585","volume":"119","author":"PK Morrish","year":"1996","unstructured":"Morrish PK, Sawle GV, Brooks DJ. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson\u2019s disease. Brain. 1996;119(Pt 2):585\u201391.","journal-title":"Brain"},{"issue":"6","key":"6403_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/jamaneurol.2014.290","volume":"71","author":"IT Hsiao","year":"2014","unstructured":"Hsiao IT, Weng YH, Hsieh CJ, et al. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography. JAMA Neurol. 2014;71(6):758\u201366.","journal-title":"JAMA Neurol"},{"issue":"1","key":"6403_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2967\/jnumed.113.121897","volume":"55","author":"SC Lin","year":"2014","unstructured":"Lin SC, Lin KJ, Hsiao IT, et al. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET. J Nucl Med. 2014;55(1):73\u20139.","journal-title":"J Nucl Med"},{"key":"6403_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.arr.2015.12.009","volume":"30","author":"DJ Brooks","year":"2016","unstructured":"Brooks DJ. Molecular imaging of dopamine transporters. Ageing Res Rev. 2016;30:114\u201321.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"6403_CR15","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/mds.27316","volume":"33","author":"P Fazio","year":"2018","unstructured":"Fazio P, Svenningsson P, Cselenyi Z, Halldin C, Farde L, Varrone A. Nigrostriatal dopamine transporter availability in early Parkinson\u2019s disease. Mov Disord. 2018;33(4):592\u20139.","journal-title":"Mov Disord"},{"issue":"Pt 11","key":"6403_CR16","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1093\/brain\/awr233","volume":"134","author":"R Nandhagopal","year":"2011","unstructured":"Nandhagopal R, Kuramoto L, Schulzer M, et al. Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson\u2019s disease. Brain. 2011;134(Pt 11):3290\u20138.","journal-title":"Brain"},{"issue":"Pt 11","key":"6403_CR17","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1093\/brain\/awp209","volume":"132","author":"R Nandhagopal","year":"2009","unstructured":"Nandhagopal R, Kuramoto L, Schulzer M, et al. Longitudinal progression of sporadic Parkinson\u2019s disease: a multi-tracer positron emission tomography study. Brain. 2009;132(Pt 11):2970\u20139.","journal-title":"Brain"},{"issue":"12","key":"6403_CR18","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2967\/jnumed.119.227140","volume":"60","author":"V Kaasinen","year":"2019","unstructured":"Kaasinen V, Kankare T, Joutsa J, Vahlberg T. Presynaptic striatal dopaminergic function in atypical parkinsonism: a metaanalysis of imaging studies. J Nucl Med. 2019;60(12):1757\u201363.","journal-title":"J Nucl Med"},{"issue":"2","key":"6403_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2967\/jnumed.109.070094","volume":"51","author":"N Okamura","year":"2010","unstructured":"Okamura N, Villemagne VL, Drago J, et al. In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133. J Nucl Med. 2010;51(2):223\u20138.","journal-title":"J Nucl Med"},{"issue":"4","key":"6403_CR20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1001\/archneur.59.4.580","volume":"59","author":"MJVM Ribeiro","year":"2002","unstructured":"Ribeiro MJVM, Loc\u2019h C, Dupel C, Nguyen JP, Ponchant M, et al. Dopaminergic function and dopamine transporter binding assessed with positron emission tomography in Parkinson disease. Arch Neurol. 2002;59(4):580\u20136.","journal-title":"Arch Neurol"},{"issue":"1","key":"6403_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13550-023-01000-6","volume":"13","author":"TEH Justesen","year":"2023","unstructured":"Justesen TEH, Borghammer P, Aanerud J, Hovind P, Marner L. Sertraline treatment influences [(18)F]FE-PE2I PET imaging for parkinsonism. EJNMMI Res. 2023;13(1):46.","journal-title":"EJNMMI Res"},{"issue":"7","key":"6403_CR22","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1007\/s00259-023-06171-x","volume":"50","author":"Y Chahid","year":"2023","unstructured":"Chahid Y, Sheikh ZH, Mitropoulos M, Booij J. A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [(123)I]I-FP-CIT SPECT in routine practice. Eur J Nucl Med Mol Imaging. 2023;50(7):1974\u201387.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"6403_CR23","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1177\/0271678X19828916","volume":"40","author":"Z Huang","year":"2020","unstructured":"Huang Z, Jiang C, Li L, et al. Correlations between dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder. J Cereb Blood Flow Metab. 2020;40(3):552\u201362.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"13","key":"6403_CR24","doi-asserted-by":"publisher","first-page":"e1344","DOI":"10.1212\/WNL.0000000000009168","volume":"94","author":"HS Yoo","year":"2020","unstructured":"Yoo HS, Lee S, Chung SJ, et al. Clinical and striatal dopamine transporter predictors of beta-amyloid in dementia with Lewy bodies. Neurology. 2020;94(13):e1344\u201352.","journal-title":"Neurology"},{"key":"6403_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.parkreldis.2021.11.033","volume":"94","author":"DG Park","year":"2022","unstructured":"Park DG, Kang SY, Hong JY, Sunwoo MK, Yoon JH. Factors associated with motor severity in vascular parkinsonism with normal dopamine transporter imaging. Parkinsonism Relat Disord. 2022;94:99\u2013103.","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"6403_CR26","first-page":"1688","volume":"45","author":"M Lorberboym","year":"2004","unstructured":"Lorberboym M, Djaldetti R, Melamed E, Sadeh M, Lampl Y. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. J Nucl Med. 2004;45(10):1688\u201393.","journal-title":"J Nucl Med"},{"issue":"11","key":"6403_CR27","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1001\/jamaneurol.2020.2786","volume":"77","author":"FT Liu","year":"2020","unstructured":"Liu FT, Wang J, Chen Y. Lost dopaminergic bindings in the caudate of a patient with frontotemporal lobar degeneration-motor neuron disease. JAMA Neurol. 2020;77(11):1448\u20139.","journal-title":"JAMA Neurol"},{"issue":"1","key":"6403_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/mds.27183","volume":"33","author":"W Li","year":"2018","unstructured":"Li W, Lao-Kaim NP, Roussakis AA, et al. (11) C-PE2I and (18) F-Dopa PET for assessing progression rate in Parkinson\u2019s: a longitudinal study. Mov Disord. 2018;33(1):117\u201327.","journal-title":"Mov Disord"},{"issue":"Suppl 4","key":"6403_CR29","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S1353-8020(09)70833-8","volume":"15","author":"G Biju","year":"2009","unstructured":"Biju G, de la Fuente-Fernandez R. Dopaminergic function and progression of Parkinson\u2019s disease: PET findings. Parkinsonism Relat Disord. 2009;15(Suppl 4):S38-40.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"6403_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00415-006-0322-9","volume":"254","author":"J Wang","year":"2007","unstructured":"Wang J, Zuo CT, Jiang YP, et al. 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson\u2019s disease in various Hoehn & Yahr stages. J Neurol. 2007;254(2):185\u201390.","journal-title":"J Neurol"},{"issue":"12","key":"6403_CR31","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.parkreldis.2015.10.017","volume":"21","author":"SY Liu","year":"2015","unstructured":"Liu SY, Wu JJ, Zhao J, et al. Onset-related subtypes of Parkinson\u2019s disease differ in the patterns of striatal dopaminergic dysfunction: a positron emission tomography study. Parkinsonism Relat Disord. 2015;21(12):1448\u201353.","journal-title":"Parkinsonism Relat Disord"},{"key":"6403_CR32","doi-asserted-by":"publisher","unstructured":"Wenning GK, Stankovic I, Vignatelli L, et al. The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord. 2022;37(6):1131\u201348. https:\/\/doi.org\/10.1002\/mds.29005.","DOI":"10.1002\/mds.29005"},{"issue":"2","key":"6403_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/ane.12932","volume":"138","author":"LL Bu","year":"2018","unstructured":"Bu LL, Liu FT, Jiang CF, et al. Patterns of dopamine transporter imaging in subtypes of multiple system atrophy. Acta Neurol Scand. 2018;138(2):170\u20136.","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"6403_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018301","volume":"6","author":"R Cilia","year":"2011","unstructured":"Cilia R, Rossi C, Frosini D, et al. Dopamine transporter SPECT imaging in corticobasal syndrome. PLoS ONE. 2011;6(5): e18301.","journal-title":"PLoS ONE"},{"key":"6403_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.998255","volume":"14","author":"MJ Chen","year":"2022","unstructured":"Chen MJ, Lu JY, Li XY, et al. Striatal dopaminergic lesions contributed to the disease severity in progressive supranuclear palsy. Front Aging Neurosci. 2022;14: 998255.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"6403_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/ane.13653","volume":"146","author":"Q Chen","year":"2022","unstructured":"Chen Q, Li X, Li L, et al. Dopamine transporter imaging in progressive supranuclear palsy: severe but nonspecific to subtypes. Acta Neurol Scand. 2022;146(3):237\u201345. https:\/\/doi.org\/10.1111\/ane.13653.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"6403_CR37","first-page":"CD010633","volume":"1","author":"J McCleery","year":"2015","unstructured":"McCleery J, Morgan S, Bradley KM, Noel-Storr AH, Ansorge O, Hyde C. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies. Cochrane Database Syst Rev. 2015;1(1):CD010633.","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"6403_CR38","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s00259-016-3312-x","volume":"43","author":"JJ van der Zande","year":"2016","unstructured":"van der Zande JJ, Booij J, Scheltens P, Raijmakers PG, Lemstra AW. [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies. Eur J Nucl Med Mol Imaging. 2016;43(6):1060\u20136.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"6403_CR39","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s00259-016-3323-7","volume":"43","author":"F Nobili","year":"2016","unstructured":"Nobili F, Arnaldi D, Morbelli S. Is dopamine transporter invariably impaired at the time of diagnosis in dementia with Lewy bodies? Eur J Nucl Med Mol Imaging. 2016;43(6):1056\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"44","key":"6403_CR40","first-page":"747","volume":"116","author":"R Buchert","year":"2019","unstructured":"Buchert R, Buhmann C, Apostolova I, Meyer PT, Gallinat J. Nuclear imaging in the diagnosis of clinically uncertain parkinsonian syndromes. Dtsch Arztebl Int. 2019;116(44):747\u201354.","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"6403_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s43657-022-00079-6","volume":"3","author":"J Lu","year":"2022","unstructured":"Lu J, Wang M, Wu P, et al. Adjustment for the age- and gender-related metabolic changes improves the differential diagnosis of parkinsonism. Phenomics. 2022;3(1):50\u201363.","journal-title":"Phenomics"},{"issue":"6","key":"6403_CR42","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.parkreldis.2013.02.013","volume":"19","author":"P Wu","year":"2013","unstructured":"Wu P, Wang J, Peng S, et al. Metabolic brain network in the Chinese patients with Parkinson\u2019s disease based on 18F-FDG PET imaging. Parkinsonism Relat Disord. 2013;19(6):622\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"6403_CR43","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1002\/hbm.24044","volume":"39","author":"J Ge","year":"2018","unstructured":"Ge J, Wu J, Peng S, et al. Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: multivariate and univariate analyses in American and Chinese patient cohorts. Hum Brain Mapp. 2018;39(7):2842\u201358.","journal-title":"Hum Brain Mapp"},{"key":"6403_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102416","volume":"28","author":"B Shen","year":"2020","unstructured":"Shen B, Wei S, Ge J, et al. Reproducible metabolic topographies associated with multiple system atrophy: network and regional analyses in Chinese and American patient cohorts. Neuroimage Clin. 2020;28: 102416.","journal-title":"Neuroimage Clin"},{"issue":"1","key":"6403_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s43657-022-00077-8","volume":"3","author":"F-T Liu","year":"2022","unstructured":"Liu F-T, Lu J-Y, Sun Y-M, et al. Dopaminergic dysfunction and glucose metabolism characteristics in parkin-induced early-onset Parkinson\u2019s disease compared to genetically undetermined early-onset Parkinson\u2019s disease. Phenomics. 2022;3(1):22\u201333.","journal-title":"Phenomics"},{"key":"6403_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2021.11.035","volume":"95","author":"Q Xu","year":"2022","unstructured":"Xu Q, Jiang C, Ge J, et al. The impact of probable rapid eye movement sleep behavior disorder on Parkinson\u2019s disease: a dual-tracer PET imaging study. Parkinsonism Relat Disord. 2022;95:47\u201353.","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"6403_CR47","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1007\/s00259-022-05804-x","volume":"49","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Wu P, Wu J, et al. Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning. Eur J Nucl Med Mol Imaging. 2022;49(8):2798\u2013811.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06403-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06403-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06403-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T04:03:49Z","timestamp":1704686629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06403-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["6403"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06403-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"23 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board approval was waivered for this consensus report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}